Tony Coles

N. Anthony Coles, also known as Tony Coles, is an American physician and the President and CEO of Cerevel Therapeutics.
Coles was the Founder and CEO of Yumanity Therapeutics, the CEO and President of Onyx Pharmaceuticals, CEO of NPS Pharmaceuticals; and has held executive positions at Vertex Pharmaceuticals, Bristol-Myers Squibb, and Merck & Co.
In 2015, Coles was made a member of the Precision Medicine Initiative team created by President Barack Obama to work with the National Institutes of Health and other bodies to promote the development of therapeutics based on individual biology.
Early life and education
Coles was born in Roanoke, Virginia, on 17 May 1960.
He received a bachelor's degree from Johns Hopkins University, a Master's in Public Health from Harvard University, and an M.D. from Duke University. Coles completed his internal medicine and cardiology residency training at Massachusetts General Hospital.
Coles joined NPS Pharmaceuticals in 2005 as the CEO and a member of the board of directors.
From 2008 to 2013, Coles served as the CEO, President, and Chairman of the Board of Directors of Onyx Pharmaceuticals, a biopharmaceutical company that was focused on creating cancer therapies. During his tenure at Onyx Pharmaceuticals, Coles helped launch two novel cancer medicines.
In 2014, Coles co-founded Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on developing disease-modifying agents for neurodegenerative diseases like , , and Amyotrophic Lateral Sclerosis and Fronto-temporal Lobar Dementia. He served as the President and CEO. Coles is still a member of the Board of Directors at Yumanity Therapeutics.
In 2015, Coles was made a member on the Board of Directors at CRISPR Therapeutics. CRISPR Therapeutics is a biopharmaceutical company focused on developing gene-based therapies for patients with serious diseases. Coles also served as an Executive Chairperson of the Board of Directors since December 2018.
Honors
On 9 August 2016, during the Johns Hopkins Carey Business School's commencement ceremony, Coles and his wife, Robyn, were awarded the Dean's Medal by the dean of Carey Business School, Bernard T. Ferrari. The Dean's Medal recognizes extraordinary service, philanthropy, and leadership on behalf of Carey School of Business. The initiative was created in an effort to develop specific disease prevention and treatment options according to the unique genes, environment, and lifestyle of a patient. The main objectives of the initiative include: more and better treatments for cancer, creation of national research cohort, protecting privacy, modernizing the regulatory landscape, and creating relationships with existing research cohorts and private sectors.
Personal life
Coles is married to Robyn Coles and has three children.<ref name=":0" />

Main Menu

See Also

Main Menu